Biofluidica
Provider of liquid biopsy tests using CTCs. The flagship system uses a capture bed coated with specific antibodies to capture and separate CTCs from blood samples for analysis. The system has been clinically validated for pancreatic cancer, colorectal cancer, ovarian cancer, and breast cancer. The company was founded in 2007 and headquartered in Chapel Hill, United States. It has raised $18.1M in series b funding,…
Funding snapshot
About
Provider of liquid biopsy tests using CTCs. The flagship system uses a capture bed coated with specific antibodies to capture and separate CTCs from blood samples for analysis. The system has been clinically validated for pancreatic cancer, colorectal cancer, ovarian cancer, and breast cancer. The company was founded in 2007 and headquartered in Chapel Hill, United States. It has raised $18.1M in series b funding, with backing from Mizzou, NIH, HHS. The company operates in the Life Sciences - Oncology, Life Sciences - Clinical Genomics, Life Sciences - Genomics space. Its offerings span Oncology - In-Vitro Diagnostic Tests - Blood Cancer.
Business model
Oncology > In-Vitro Diagnostic Tests > Blood Cancer,
Genomics > Applied Genomics > Clinical Genomics > Diagnostics > Sequencing-based > Liquid Biopsy > DNA
Institutional investors
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.